Video Shorts

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
3 months ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
3 months ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
3 months ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
3 months ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
3 months ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
3 months ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
3 months ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
3 months ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
3 months ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
3 months ago

1:01
Market Watch Rx: Merck Joins Top Gainers
4 months ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
4 months ago
by
Michael Christel(+2 more)

0:34
Takeaways from Day One at Access USA 2026
4 months ago
by
Nicholas Jacobus(+1 more)

1:01
Market Watch Rx: Intellia Therapeutics Leads Gainers
4 months ago
by
Nicholas Jacobus

1:08
What You Need to Know: MFN, Healthcare Spending, and Compounded Medications
4 months ago
by
Mike Hollan

0:42
What Can Help Patient Support Operations?
4 months ago
by
Nicholas Jacobus(+1 more)

1:41
2026 Drug Pipeline Report
4 months ago
by
Michael Christel

0:51
Measuring Good Patient Access from Bad Patient Access
4 months ago
by
Nicholas Jacobus(+1 more)

0:30
Can't Afford Your Meds? Watch This
4 months ago
by
Nicholas Jacobus(+1 more)

1:05
Market Watch Rx: Pfizer Joins Top Gainers
4 months ago
by
Nicholas Jacobus

1:03
Measuring the AI Bubble
4 months ago
by
Michael Christel(+2 more)

0:59
Market Watch Rx: IQVIA Joins Top Gainers
4 months ago
by
Nicholas Jacobus

0:53
FDA Drops Two-Trial Rule for New Drugs
4 months ago
by
Nicholas Jacobus(+1 more)

0:51
Market Watch Rx: Moderna Remains Amongst Top Gainers
5 months ago
by
Nicholas Jacobus

0:38
Europe’s Innovation Edge?
5 months ago
by
Michael Christel(+1 more)

0:53
Future of Healthcare: Hybrid Drug Payment System
5 months ago
by
Nicholas Jacobus(+1 more)

1:03
Market Watch Rx: Moderna Leads Gainers
5 months ago
by
Nicholas Jacobus

0:53
The State of Pharma TV Advertising
5 months ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: AstraZeneca Among Top Gainers
5 months ago
by
Nicholas Jacobus

1:05
The EQ Imperative for Life Science CEOs
5 months ago
by
Michael Christel(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan
2
Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics
3
FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease
4
Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD
5
